D108 - Framework for the supply of Adult and Paediatric PN Products

Description

The current contract is due to expire on 31 July 2026. In order to maintain continuity of patient care and ensure uninterrupted product and service delivery, EMPC intends to extend the existing agreements with the current Awarded Suppliers beyond this date on an interim basis. EMPC has explored the option of accessing an alternative Hub Framework; however, this approach has proven unsuccessful. As a result, a new competitive procurement exercise is required. The new tender is planned for publication in summer 2026 and will include premarket engagement in line with procurement best practice. Following completion of the procurement, a UK 06 Contract Award Notice and UK07 Contract Details Notice will be published on Find a Tender in accordance with the Procurement Act 2023. The interim extension will be limited in scope and duration to the minimum necessary to complete the new procurement. This extension has been awarded to Fresenius Kabi Ltd B Braun Medical Baxter Healthcare Ltd ITH Pharma Ltd